AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

35 hedge funds and large institutions have $15.6M invested in AVEO Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

77% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 30

Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.06M
Puts
$3.54M
Net Calls
Net Calls Change

Top Buyers

1
+$406K
2
+$142K
3
+$35K
4
WA
WealthTrust Axiom
Pennsylvania
+$28.7K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$23.5K

Top Sellers

1
-$212K
2
-$61K
3
-$50K
4
CAN
Cetera Advisor Networks
California
-$42K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$35.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4K
27
$3K
28
$2K
29
$2K
30
$2K
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3